Earnings calendar/REGN
Regeneron Pharmaceuticals, Inc. (REGN)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 27, 2026
Consensus estimate row
EPS target
$13.07
Street estimate
Revenue target
$4.34B
Street estimate
Trailing EPS (avg 4Q)
$11.76
Beat rate last 4: 100%
Latest EPS YoY
+10.9%
vs 2025-08-01
Latest revenue YoY
+16.7%
How results look so far
Trailing revenue (avg 4Q)
$3.88B
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 30, 2026
EPS beat
EPS actual / est
$14.29 / $10.16
+40.6%
Revenue actual / est
$4.29B / $3.82B
+12.4%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/28/2026upcoming | $15.48 | Pending | — | $4.53B | Pending | — |
| 10/27/2026upcoming | $13.07 | Pending | — | $4.34B | Pending | — |
| 7/30/2026 | $10.16 | $14.29 | +40.6% | $3.82B | $4.29B | +12.4% |
| 5/5/2026upcoming | $8.08 | Pending | — | — | Pending | — |
| 4/29/2026 | $8.91 | $9.47 | +6.3% | $3.48B | $3.61B | +3.6% |
| 2/3/2026upcoming | $10.65 | Pending | — | — | Pending | — |
| 1/30/2026 | $10.74 | $11.44 | +6.5% | $3.81B | $3.88B | +1.9% |
| 10/28/2025 | $9.65 | $11.83 | +22.6% | $3.59B | $3.75B | +4.5% |
| 8/1/2025 | $8.43 | $12.89 | +52.9% | $3.29B | $3.68B | +11.8% |
| 4/29/2025 | $8.62 | $8.22 | -4.6% | $3.25B | $3.03B | -6.8% |
| 2/4/2025 | $11.21 | $12.07 | +7.7% | $3.74B | $3.79B | +1.3% |
| 10/31/2024 | $11.69 | $12.46 | +6.6% | $3.67B | $3.72B | +1.2% |
| 8/1/2024 | $10.61 | $11.56 | +9.0% | $3.38B | $3.55B | +4.8% |
| 5/2/2024 | $10.17 | $9.55 | -6.1% | $3.23B | $3.15B | -2.5% |
| 2/2/2024 | $10.73 | $11.86 | +10.5% | $3.29B | $3.43B | +4.2% |
| 11/2/2023 | $10.72 | $11.59 | +8.1% | $3.22B | $3.36B | +4.4% |
| 8/3/2023 | $9.84 | $10.24 | +4.1% | $3.02B | $3.16B | +4.7% |
| 5/4/2023 | $9.25 | $10.09 | +9.1% | $3.00B | $3.16B | +5.4% |
| 2/3/2023 | $10.03 | $12.56 | +25.2% | $3.12B | $3.41B | +9.3% |
| 11/3/2022 | $9.48 | $11.14 | +17.5% | $2.92B | $2.94B | +0.7% |